• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Antonio Anzueto - Articles and news items

Professor Antonio Anzueto, Professor of Medicine Pulmonary/Critical Care Medicine, University of Texas Health Science Center at San Antonio, Texas, USA

Landmark TIOSPIRTM trial reinforces importance of SPIRIVA® in both available formulations as the world’s leading maintenance therapy for chronic obstructive pulmonary disease (COPD)

Industry news, News / 9 September 2013 / Boehringer Ingelheim

TIOSPIR™, with over 17,000 COPD patients included and one of the largest international COPD trials ever conducted…

Boehringer Ingelheim logo

SPIRIVA®* celebrates 10 years of ongoing commitment to patients and advancing clinical innovation in COPD

Industry news, News / 3 September 2012 / Boehringer Ingelheim

SPIRIVA® is the most prescribed COPD maintenance treatment worldwide…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +